--> -->

News​

​CAM Bioceramics and Ossiform team up for OMTEC 2022

By Ossiform | June 03, 2022 | NEWS​

As partners through several years, Ossiform, the developer of proprietary technology to produce natural, patient specific, and resorbable bone implants, and CAM Bioceramics, a leading contract development and manufacturing company of Orthobiologic Calcium Phosphates, have teamed up to showcase their service and product portfolios at OMTEC 2022.

Ossiform - Announces rebrand​

By Ossiform​ | Jan 05, 2022 | NEWS

ODENSE, January 5th, 2022 – Ossiform, We Print Bone™, is pleased to announce that it has completed its rebranding. With the approaching launch of its first bone implant for human use, the Company has rapidly grown and matured, and the rebranding marks a further step in expanding Ossiform’s commercialization activities

Patent for Ossiform’s technology granted in China

​by Ossiform | Aug 20, 2021 | NEWS​

August 10th 2021, the China National Intellectual Property Administration (CNIPA) announced that Ossiform’s patent, Feedstock for 3D printing and uses thereof no. PCT/DK2016/050323, has been granted in China.​

Ossiform – New market-oriented Chairman of the Board

​by Ossiform | June 1, 2021 | NEWS​

​ODENSE, 1st June 2021 – Ossiform, We Print Bone™, is pleased to announce that a new and highly qualified Chairman of the Board has been found.

The Company appoints Mette-Marie Harild as new Chairman of the Board if she is elected to the board of directors at Ossiform Limited’s general meeting which will take place on 15th June 2021.

Big step towards market approval and registration: Ossiform initiates QMS implementation

​by Ossiform | Dec 14, 2020 | NEWS​

December 11th, 2020, Ossiform's executive management signed the first fundamental procedures of the Quality Management System which will lay the foundation for the market approval and registration of the P3D Bone implant in the USA.

The Company has thereby commenced the implementation of a medical device Quality Management System with a view to achieve ISO 13485 certification – the international standard for quality management systems in the medical device industry. 

New research paper: Treating mouse skull defects with 3D-printed fatty acid and tricalcium phosphate implants

​by Ossiform | Nov 13, 2020 | NEWS​

View the results of the new peer-reviewed paper on the performance of P3D Bone as a novel form of individualized ceramic bone implants.​

Patent for Ossiform’s technology granted in the USA

​by Ossiform | Jun 10, 2020 | NEWS​

June 9th 2020, the United States Patent and Trademark office (USPTO) announced that Ossiform’s patent, Feedstock for 3D printing and uses thereof no. PCT/DK2016/050323, has been granted in the USA.

This marks Ossiform’s second patent issuance, following the approval and publication of its European patent, EP/3359318, in April 2020.​

Ossiform raises capital through West Hill

​by Ossiform | May 18, 2020 | NEWS​

ODENSE, May 18th, 2020 – Ossiform, We Print Bone™, is pleased to announce that the £2.5 million capital raise through West Hill Capital was heavily oversubscribed. Ossiform has developed a disruptive and patented technology to be used to produce and supply P3D Bone; 3D printed patient-specific, resorbable bone implants that remodel into real living bone. The first research products have been launched, the P3D Scaffolds, bringing natural bone environments into laboratories.​

Ossiform enters U.S. partnership with Asimov Ventures

​by Ossiform | May 4, 2020 | NEWS​

Ossiform receives investment from New York based venture capital firm, Asimov Ventures, and enters valuable U.S. partnership. The partnership with Asimov Ventures marks the Company’s first step into the U.S. market, looking toward an early commercialization of P3D Bone in the USA.​

Ossiform Featured in WIRED Magazine

​by Ossiform | Feb 13, 2020 | NEWS​

Ossiform is featured in a story by WIRED Magazine about our work to develop better, healthier bone implants that remodel into real living bone tissue.

The story was first published in the March / April 2020 issue of WIRED magazine.​

Our mission is your benefits

Our mission is to provide 3D printed natural bone implants to reduce complications, improve functional & aesthetic outcomes, and obtain faster recovery.

Natural bone porosity, optimized for bone regeneration 

The unique structure of the P3D Bone is designed to facilitate the natural forming of new bone.

Remodels into real living bone

The natural material and structure ensure effective remodeling of the implant into new vascularized bone.

Patient specific - designed with the patient's uniqueness in mind

The P3D Bone is 3D printed to enable a full restoration of the functionality and appearance of bones.

Resorbable material with structural support

P3D Bone eliminates the need to harvest bone as well as the need for permanent and ill-fitting implants.

P3D Bone Void Filler is expected to launch in 2023

Our first 3D printed, resorbable P3D Bone with modifiable dimensions and a lifelike bone architecture

P3D Bone Patient Specific Implant is expected to launch in 2024

Our patient specific and resorbable P3D Bone based on the patient’s own CT/MRI scan data

We Print Bone​™

Contact us here

Contact us for questions, general inquiries, or to request a quote.
We strive to provide you with highest quality service and expertise in medical 3D printing.

 
 
 
Please make sure all required fields are filled out correctly

Do you have questions?

Give us a call or write to us by email: info@ossiform.com

We will get back to you as soon as possible.​

logo-footer_2

Ossiform ApS - We Print Bone™

​Oslogade 1, 5000 Odense C​, Denmark

CVR. 38838512

facebook  linkedin  twitter  instagram